Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2822049 | 1.00 | CA2 (0.34) | CA2ALDH1A1 | |
| SCHEMBL10866200 | 1.00 | CA2 (0.34) | CA2ALDH1A1 | |
| SCHEMBL10409636 | 1.00 | CA2 (0.34) | CA2ALDH1A1 | |
| SCHEMBL824022 | 0.91 | — | — | |
| SCHEMBL239368 | 0.88 | MAPK1 (0.35) | ALDH1A1 | |
| SCHEMBL1476894 | 0.88 | MAPK1 (0.35) | ALDH1A1 | |
| SCHEMBL16017770 | 0.88 | MAPK1 (0.35) | ALDH1A1 | |
| SCHEMBL20250956 | 0.88 | MAPK1 (0.35) | ALDH1A1 | |
| SCHEMBL20250955 | 0.88 | MAPK1 (0.35) | ALDH1A1 | |
| SCHEMBL15813670 | 0.88 | MAPK1 (0.35) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020162156-A1 | COMPOUND AND LIGHT EMITTING ELEMENT USING SAME | 住友化学株式会社 | 2020-08-13 | — | — | WO | disclosed |
| EP-3306694-B1 | LIGHT-EMITTING ELEMENT AND METHOD FOR MANUFACTURING SAME | SUMITOMO CHEMICAL CO (JP) | 2020-08-12 | — | — | EP | disclosed |
| US-20180147202-A1 | TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE | Arvinas, Inc. (US) | 2018-05-31 | — | — | US | disclosed |
| US-20180147202-A1 | TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE | Arvinas, Inc. (US) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180147202-A1 | TANK-BINDING KINASE-1 PROTACs AND ASSOCIATED METHODS OF USE | TBK1, TBKBP1, TNKS | CA2 4144/4885ALDH1A1 4201/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.